A jury might really sink its teeth into Norex Petroleum's claims against a collection of Russian billionaires and oil companies. But unfortunately for Norex, over the span of 10 years Pell has led the way in convincing three different courts in Manhattan to dismiss the case without ever reaching the merits.

Bank of America announced Monday that it will pay $1.6 billion to the bond insurer MBIA Inc., bringing an end to one of the most vigorously contested disputes to grow out of the mortgage crisis.

The odds of a surprise turnaround for the banks fighting the Federal Housing Finance Agency are looking slimmer and slimmer.

The plaintiffs lawyers leading El Paso shareholders' assault on the company's planned $21 billion acquisition by Kinder Morgan lost their bid to enjoin the sale late Wednesday, but they sure got the judge's attention. Can they translate the opprobrium of Delaware Chancery Court chancellor Leo Strine Jr. into a big payday--and more than a little embarrassment for El Paso advisor Goldman Sachs?

After cycling through nine sets of his own lawyers, Paul Ceglia, the man claiming to own at least half of Facebook, wants a judge to exile Facebook's lawyers at Gibson Dunn and strip them of their fees. Facebook's lawyers, meanwhile, want a judge to force Ceglia to turn over a letter from Kasowitz Benson they say shows once and for all that he's a fraud.

The Financial Services Authority was upset that Goldman Sachs International waited until April 16--the date that the Securities and Exchange Commission sued Goldman Sachs & Co.--to let it know that the SEC was investigating Goldman over its Abacus investments. Goldman told the FSA that it didn't believe that the SEC probe would amount to anything material.

The publishers of Lance Armstrong’s autobiographical books have moved to dismiss a proposed class action asserting that they misled consumers into believing they were buying an honest narrative of the disgraced cyclist's life.

Two months after opting out of a class action against Pfizer, a group of major public and private institutional investors are taking matters into their own hands. On Thursday the breakaway investors and their lawyers at Bernstein Litowitz filed their own securities fraud suit, accusing Pfizer of duping shareholders about risks associated with two once-blockbuster drugs.

Ties to U.S. plaintiffs firms may be valuable to Canadian firms pressing securities class action claims north of the border, but such relationships may also carry risks. In a decision appointing firms to lead a shareholder class action against Sino-Forest Corp., a judge in Ontario explored whether the Toronto firm Kim Orr should be disqualified from the bidding because of the firm's prominent ties with Milberg.

Overwhelmed by the pace of patent litigation news? Here's some of what you may have missed.